Wall Street analyst estimates for H.B. Fuller Company (FUL): consensus price target and buy/hold/sell recommendations.
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Building Adhesive Solutions.
Consensus price target
$62.33 (+26 % vs price $49.61)
between $55.00 and $67.00 · 3 targets published in the last quarter
Closing price, Oct 29
A twelve-month target is not a fair value: compare it with the range in the Valuation tab.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 9 |
| Hold | 6 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 15 |
| Avg rating (−2 sell to +2 buy) | 0.60 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2027-01-13 | $1.38 | ||
| 2026-09-23 | $1.52 | $1.47 | +3.4% |
| 2026-06-24 | $1.41 | $1.37 | +2.9% |
| 2026-03-25 | $0.57 | $0.56 | +2.7% |
| 2026-01-14 | $1.28 | $1.24 | +3.2% |
| 2025-09-24 | $1.26 | $1.24 | +1.6% |
| 2025-06-25 | $1.18 | $1.10 | +7.3% |
| 2025-03-26 | $0.54 | $0.49 | +9.4% |
Valuation Ratios
| P/E Ratio | 13.82 |
| Price / Book | 1.24 |
| EV / EBITDA | 8.57 |
| Dividend Yield | 1.95% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.09B | $2.31B | $3.04B | $2.90B | $2.79B | $3.28B | $3.75B | $3.51B | $3.57B | $3.47B |
| Cost of Revenue | $1.48B | $1.69B | $2.21B | $2.09B | $2.03B | $2.43B | $2.79B | $2.49B | $2.49B | $2.37B |
| Gross Profit | $609.8M | $614.8M | $833.9M | $809.0M | $757.7M | $845.1M | $963.5M | $1.02B | $1.07B | $1.10B |
| Research & Development | $28.6M | $30.1M | $35.5M | $36.6M | $37.0M | $39.3M | $44.9M | $48.6M | $49.6M | 0 |
| Selling, General & Admin | $377.9M | $425.6M | $551.6M | $531.9M | $497.8M | $550.1M | $596.4M | $595.8M | $655.6M | $701.7M |
| Operating Expenses | $406.5M | $455.6M | $587.1M | $568.5M | $534.8M | $589.4M | $641.3M | $644.4M | $705.2M | $701.7M |
| Operating Income | $203.3M | $159.2M | $246.8M | $240.5M | $222.9M | $255.7M | $322.3M | $379.5M | $368.9M | $399.1M |
| EBITDA | $272.5M | $191.6M | $412.8M | $417.3M | $383.9M | $438.1M | $490.4M | $528.6M | $490.5M | $527.1M |
| Interest Expense | $27.4M | $43.7M | $111.0M | $103.3M | $86.8M | $78.1M | $91.5M | $134.6M | $133.1M | $133.3M |
| Pre-tax Income | $174.8M | $69.3M | $164.9M | $180.3M | $165.7M | $224.5M | $257.6M | $238.5M | $186.8M | $219.2M |
| Income Tax | $50.4M | $9.8M | -$6.4M | $49.4M | $41.9M | $63.0M | $77.2M | $93.5M | $56.4M | $67.1M |
| Net Income | $124.1M | $58.2M | $171.2M | $130.8M | $123.7M | $161.4M | $180.3M | $144.9M | $130.3M | $152.0M |
| EPS | $2.48 | $1.16 | $3.38 | $2.57 | $2.38 | $3.05 | $3.37 | $2.67 | $2.37 | $2.78 |
| EPS (Diluted) | $2.42 | $1.13 | $3.29 | $2.52 | $2.36 | $2.97 | $3.26 | $2.59 | $2.30 | $2.75 |
| Shares Outstanding (Diluted) | 51.3 M | 51.6 M | 52.0 M | 52.0 M | 52.5 M | 54.3 M | 55.3 M | 56.0 M | 56.6 M | 55.4 M |
Price
| Price | $49.61 (closing price, October 29, 2026) |
| Market Cap | $2.7B |
| Exchange | NYSE |
| Country | US |
Related companies: CENX · USLM · HWKN · WDFC · SXT · CBT · PRM · SMG
Explore sector: Basic Materials · Chemicals - Specialty
More sections of FUL: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks